Wanbury (NSEI:WANBURY) - Prezzo delle azioni, notizie e analisi

WANBURY Panoramica delle azioni

Wanbury Limited produce e vende formulazioni e ingredienti farmaceutici attivi (API) in India e a livello internazionale. Maggiori dettagli

WANBURY analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	4/6
Salute finanziaria	2/6
Dividendi	0/6

Premi

Il rapporto prezzo/utile ( 14.4 x) è inferiore al mercato Indian ( 31.1 x)

Gli utili sono cresciuti del 3302.6% nell'ultimo anno

Analisi del rischio

I pagamenti degli interessi non sono ben coperti dagli utili

Grandi elementi una tantum che incidono sui risultati finanziari

Non ha una capitalizzazione di mercato significativa ( ₹8B )

Wanbury Limited Concorrenti

Albert David

BSE:524075

₹7.6b

Nectar Lifesciences

NSEI:NECLIFE

₹7.9b

Sakar Healthcare

NSEI:SAKAR

₹6.7b

Ind-Swift Laboratories

NSEI:INDSWFTLAB

₹6.3b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Wanbury
Prezzi storici delle azioni
Prezzo attuale dell'azione	₹229.26
Massimo di 52 settimane	₹290.20
Minimo di 52 settimane	₹91.00
Beta	0.53
1Variazione di 1 mese	-8.11%
Variazione a 3 mesi	17.07%
Variazione di 1 anno	151.80%
3Variazione a 3 anni	211.28%
Variazione a 5 anni	1,149.37%
Variazione dall'IPO	66.73%

Notizie e aggiornamenti recenti

Wanbury Limited (NSE:WANBURY) Surges 35% Yet Its Low P/S Is No Reason For Excitement

Sep 13

Recent updates

Wanbury Limited (NSE:WANBURY) Surges 35% Yet Its Low P/S Is No Reason For Excitement

Sep 13

Wanbury Limited (NSE:WANBURY) Might Not Be As Mispriced As It Looks

Jul 16

Statutory Earnings May Not Be The Best Way To Understand Wanbury's (NSE:WANBURY) True Position

May 24

These 4 Measures Indicate That Wanbury (NSE:WANBURY) Is Using Debt Reasonably Well

May 21

The Market Doesn't Like What It Sees From Wanbury Limited's (NSE:WANBURY) Earnings Yet

Mar 19

Wanbury Limited's (NSE:WANBURY) Shares Leap 42% Yet They're Still Not Telling The Full Story

Dec 18

Are Wanbury's (NSE:WANBURY) Statutory Earnings A Good Guide To Its Underlying Profitability?

Sep 09

Rendimenti per gli azionisti

	WANBURY	IN Pharmaceuticals	IN Mercato
7D	-11.8%	-3.2%	-3.4%
1Y	151.8%	42.8%	27.4%

Ritorno vs Industria: WANBURY ha superato il Indian Pharmaceuticals che ha restituito 42.8 % nell'ultimo anno.

Rendimento vs Mercato: WANBURY ha superato il mercato Indian che ha restituito 27.4 % nell'ultimo anno.

Volatilità dei prezzi

Is WANBURY's price volatile compared to industry and market?
WANBURY volatility
WANBURY Average Weekly Movement	7.1%
Pharmaceuticals Industry Average Movement	6.0%
Market Average Movement	6.2%
10% most volatile stocks in IN Market	9.2%
10% least volatile stocks in IN Market	4.0%

Prezzo delle azioni stabile: WANBURY non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 7% ) di WANBURY è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1988	1,491	Mohan Rayana	www.wanbury.com

Wanbury Limited produce e vende formulazioni e ingredienti farmaceutici attivi (API) in India e a livello internazionale. L'azienda offre formulazioni per ginecologia, ortopedia, ematologia, antidiabetici, nutraceutici, gastrointestinali, chirurgia dell'ictus, antibiotici, soluzioni per la tosse e il raffreddore, antinfiammatori, analgesici e medici generici. Fornisce inoltre prodotti API per le aree terapeutiche antidiabetica, antalgica, antidepressiva, antistaminica, antinfiammatoria, antiartritica, antitrombotica, antiepilettica e antiipertensiva.

Wanbury Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Wanbury con la sua capitalizzazione di mercato?
WANBURY statistiche fondamentali
Capitalizzazione di mercato	₹7.54b
Guadagni(TTM)	₹523.05m
Ricavi(TTM)	₹5.60b

14.4x

Rapporto P/E

1.3x

Rapporto P/S

WANBURY è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
WANBURY Conto economico (TTM)
Ricavi	₹5.60b
Costo del fatturato	₹2.84b
Profitto lordo	₹2.77b
Altre spese	₹2.24b
Guadagni	₹523.05m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	15.97
Margine lordo	49.35%
Margine di profitto netto	9.33%
Rapporto debito/patrimonio netto	416.9%

Come si è comportato WANBURY nel lungo periodo?

Vedi performance storica e confronto

WANBURY Panoramica delle azioni

Premi

Analisi del rischio

Wanbury Limited Concorrenti

BSE:524075

₹7.6b

NSEI:NECLIFE

₹7.9b

NSEI:SAKAR

₹6.7b

NSEI:INDSWFTLAB

₹6.3b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Wanbury Limited to Report Q2, 2025 Results on Nov 13, 2024

Wanbury Limited to Report Q2, 2025 Results on Nov 13, 2024

Wanbury Limited (NSE:WANBURY) Surges 35% Yet Its Low P/S Is No Reason For Excitement

Wanbury Limited Informs About Its New Products Launch

Wanbury Limited, Annual General Meeting, Sep 27, 2024

Wanbury Limited Announces Appointment of Pradeep Patni as CEO of India Formulation Business

Recent updates

Wanbury Limited to Report Q2, 2025 Results on Nov 13, 2024

Wanbury Limited to Report Q2, 2025 Results on Nov 13, 2024

Wanbury Limited (NSE:WANBURY) Surges 35% Yet Its Low P/S Is No Reason For Excitement

Wanbury Limited Informs About Its New Products Launch

Wanbury Limited, Annual General Meeting, Sep 27, 2024

Wanbury Limited Announces Appointment of Pradeep Patni as CEO of India Formulation Business

Investor sentiment improves as stock rises 17%

First quarter 2025 earnings released: EPS: ₹0.32 (vs ₹1.43 in 1Q 2024)

Wanbury Limited to Report Q1, 2025 Results on Aug 12, 2024

Wanbury Limited (NSE:WANBURY) Might Not Be As Mispriced As It Looks

Investor sentiment improves as stock rises 20%

Statutory Earnings May Not Be The Best Way To Understand Wanbury's (NSE:WANBURY) True Position

New minor risk - Share price stability

These 4 Measures Indicate That Wanbury (NSE:WANBURY) Is Using Debt Reasonably Well

Full year 2024 earnings released: EPS: ₹17.10 (vs ₹3.18 loss in FY 2023)

Wanbury Limited to Report Q4, 2024 Results on May 16, 2024

Less than half of directors are independent

Investor sentiment improves as stock rises 15%

The Market Doesn't Like What It Sees From Wanbury Limited's (NSE:WANBURY) Earnings Yet

Investor sentiment deteriorates as stock falls 17%

Wanbury Limited Announces Retirement of Pallavi Prakash Shedge as Independent Director

Third quarter 2024 earnings released: EPS: ₹3.14 (vs ₹1.00 loss in 3Q 2023)

Wanbury Limited to Report Q3, 2024 Results on Jan 24, 2024

Wanbury Limited's (NSE:WANBURY) Shares Leap 42% Yet They're Still Not Telling The Full Story

Wanbury Limited Approves Appointment of Pravin Dilip Pawar as the Non-Executive Independent Director

Second quarter 2024 earnings released: EPS: ₹2.25 (vs ₹0.27 loss in 2Q 2023)

Wanbury Limited to Report Q2, 2024 Results on Oct 20, 2023

New major risk - Negative shareholders equity

Estimating The Fair Value Of Wanbury Limited (NSE:WANBURY)

Wanbury Limited, Annual General Meeting, Sep 27, 2023

Wanbury Limited Appoints Mohan Kumar Rayana as Whole Time Director

First quarter 2024 earnings released: EPS: ₹1.43 (vs ₹2.22 loss in 1Q 2023)

Wanbury Limited to Report Q1, 2024 Results on Aug 11, 2023

Not Many Are Piling Into Wanbury Limited (NSE:WANBURY) Just Yet

Full year 2023 earnings released: ₹3.18 loss per share (vs ₹25.29 profit in FY 2022)

Wanbury Limited to Report Q4, 2023 Results on Jun 26, 2023

Investor sentiment improves as stock rises 19%

Wanbury Limited to Report Q4, 2023 Results on May 30, 2023

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: ₹1.00 loss per share (vs ₹0.12 profit in 3Q 2022)

Wanbury Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: ₹0.27 loss per share (vs ₹0.17 loss in 2Q 2022)

Investor sentiment deteriorated over the past week

Wanbury Limited to Report Q2, 2023 Results on Nov 11, 2022

Investor sentiment improved over the past week

Wanbury Limited, Annual General Meeting, Sep 28, 2022

First quarter 2023 earnings released: ₹2.22 loss per share (vs ₹0.28 loss in 1Q 2022)

Investor sentiment improved over the past week

Wanbury Limited to Report Q1, 2023 Results on Aug 10, 2022

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹25.29 (vs ₹5.04 loss in FY 2021)

Wanbury Limited to Report Q4, 2022 Results on Jun 22, 2022

Wanbury Limited announced that it expects to receive INR 143.0625 million in funding from Expert Chemicals (India) Pvt. Ltd.

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Wanbury Limited to Report Q3, 2022 Results on Feb 08, 2022

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Calculating The Intrinsic Value Of Wanbury Limited (NSE:WANBURY)

First quarter 2022 earnings released: ₹0.28 loss per share (vs ₹4.47 loss in 1Q 2021)

Full year 2021 earnings released: ₹5.04 loss per share (vs ₹26.90 profit in FY 2020)